![]()
|
|
||||||||
J. Biol. Chem., Vol. 280, Issue 21, 20516-20523, May 27, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

¶

From the
Department of Molecular Cell Biology and Immunology, Vrije Universiteit Medical Center, Amsterdam 1007 MB, The Netherlands, the
Department of Animal Physiology, Uppsala University, Uppsala SE-75123, Sweden, the ¶MediCity Research Laboratory, University of Turku and National Public Health Institute, Turku FIN-20520, Finland, the ||Turku Centre for Biotechnology, University of Turku and Åbo Akademi University, Turku FIN-20520, Finland, and the **Seikagaku Corporation, Central Research Laboratories, Tokyo 207-0021, Japan
The sulfated glycosaminoglycan heparan sulfate (HS) is found ubiquitously on cell surfaces, in the extracellular matrix, and intracellularly as HS proteoglycans. Because of the structural heterogeneity of HS, tissue-derived HS preparations represent a mixture of HS chains originating from different cell types and tissue loci. Monoclonal anti-HS antibodies have been employed to detect the localization of specific HS epitopes in tissues, but limited information has been available on the saccharide structures recognized by the antibodies. We have studied the saccharide epitope structures of four anti-HS antibodies, HepSS1, JM13, JM403, and 10E4, which all recognize distinct HS species as demonstrated by different patterns of immunoreactivity upon staining of embryonic rat and adult human tissues. The epitopes recognized by JM13 and HepSS1 were found almost exclusively in basement membrane HS, whereas JM403 and 10E4 reacted also with cell-associated HS species. The binding of HepSS1, JM403, and 10E4 to HS was dependent on the GlcN N-substitution of the polysaccharide rather than O-sulfation. HepSS1 thus interacted with N-sulfated HS domains, JM403 binding was critically dependent on N-unsubstituted GlcN residues, and 10E4 bound to "mixed" HS domains containing both N-acetylated and N-sulfated disaccharide units. By contrast, JM13 binding seemed to require the presence of 2-O-sulfated glucuronic acid residues.
Received for publication, February 23, 2005
* This work was supported by the Academy of Finland Grants 78400 and 20688, the Sigrid Jusélius Foundation, Finnish cancer organizations, K. Albin Johanssons Stiftelse, Polysackaridforskning AB, and the Mizutani Foundation for Glycoscience. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: Turku Centre for Biotechnology, University of Turku and Åbo Akademi University, Tykistökatu 6, FIN-20520 Turku, Finland. Tel.: 358-2-333-8649; Fax: 358-2-333-8000; E-mail: markku.salmivirta{at}btk.fi.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
Y. Pan, C. Carbe, A. Powers, E. E. Zhang, J. D. Esko, K. Grobe, G.-S. Feng, and X. Zhang Bud specific N-sulfation of heparan sulfate regulates Shp2-dependent FGF signaling during lacrimal gland induction Development, January 15, 2008; 135(2): 301 - 310. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. A. M. Celie, R. M. Reijmers, E. M. Slot, R. H. J. Beelen, M. Spaargaren, P. M. ter Wee, S. Florquin, and J. van den Born Tubulointerstitial heparan sulfate proteoglycan changes in human renal diseases correlate with leukocyte influx and proteinuria Am J Physiol Renal Physiol, January 1, 2008; 294(1): F253 - F263. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Vanpouille, A. Deligny, M. Delehedde, A. Denys, A. Melchior, X. Lienard, M. Lyon, J. Mazurier, D. G. Fernig, and F. Allain The Heparin/Heparan Sulfate Sequence That Interacts with Cyclophilin B Contains a 3-O-Sulfated N-Unsubstituted Glucosamine Residue J. Biol. Chem., August 17, 2007; 282(33): 24416 - 24429. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A.H. Jarvinen and E. Ruoslahti Molecular Changes in the Vasculature of Injured Tissues Am. J. Pathol., August 1, 2007; 171(2): 702 - 711. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Abramsson, S. Kurup, M. Busse, S. Yamada, P. Lindblom, E. Schallmeiner, D. Stenzel, D. Sauvaget, J. Ledin, M. Ringvall, et al. Defective N-sulfation of heparan sulfate proteoglycans limits PDGF-BB binding and pericyte recruitment in vascular development Genes & Dev., February 1, 2007; 21(3): 316 - 331. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Pan, A. Woodbury, J. D. Esko, K. Grobe, and X. Zhang Heparan sulfate biosynthetic gene Ndst1 is required for FGF signaling in early lens development Development, December 15, 2006; 133(24): 4933 - 4944. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. van den Born, B. Pisa, M. A. H. Bakker, J. W. A. M. Celie, C. Straatman, S. Thomas, G. C. Viberti, L. Kjellen, and J. H. M. Berden No Change in Glomerular Heparan Sulfate Structure in Early Human and Experimental Diabetic Nephropathy J. Biol. Chem., October 6, 2006; 281(40): 29606 - 29613. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. B. t. Dam, S. Kurup, E. M. A. van de Westerlo, E. M. M. Versteeg, U. Lindahl, D. Spillmann, and T. H. van Kuppevelt 3-O-Sulfated Oligosaccharide Structures Are Recognized by Anti-heparan Sulfate Antibody HS4C3 J. Biol. Chem., February 24, 2006; 281(8): 4654 - 4662. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. D. Bassett, R. Swinhoe, O. Chassande, J. Samarut, and G. R. Williams Thyroid Hormone Regulates Heparan Sulfate Proteoglycan Expression in the Growth Plate Endocrinology, January 1, 2006; 147(1): 295 - 305. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |